Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
GuruFocus Financial Strength Rank measures how strong a company's financial situation is. It is rated on a scale of 1 to 10 and is based on these factors:
1. The debt burden that the company has as measured by its Interest Coverage (current year). The higher, the better.
2. Debt to revenue ratio. The lower, the better.
3. Altman Z-Score.
4. Other debt related ratios.
A higher score indicates a stronger financial position, with companies rated 7 or above considered financially stable and unlikely to face distress. Conversely, a score of 3 or below suggests potential financial difficulties, indicating a higher risk of distress.
XRF Scientific's Interest Coverage for the quarter that ended in Dec. 2025 was 133.98.
XRF Scientific's debt to revenue ratio for the quarter that ended in Dec. 2025 was 0.04.
As of today, XRF Scientific's Altman Z-Score is 14.27.
The rank is rated on a scale of 1 to 10. A higher score indicates a stronger financial position, with companies rated 7 or above considered financially stable and unlikely to face distress. Conversely, a score of 3 or below suggests potential financial difficulties, indicating a higher risk of distress.
XRF Scientific has the Financial Strength Rank of 8. It shows strong financial strength and is unlikely to fall into distressed situations.
XRF Scientific Financial Strength Related Terms
ASX:XRF vs MMM, HON: Financial Strength Comparison
For the Conglomerates subindustry, XRF Scientific's Financial Strength, along with its competitors' market caps and Financial Strength data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
XRF Scientific Financial Strength vs Conglomerates Industry
For the Conglomerates industry and Industrials sector, XRF Scientific's Financial Strength distribution charts can be found below:
* The bar in red indicates where XRF Scientific's Financial Strength falls into.
Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense:
The higher the ratio, the stronger the company's financial strength is.
Good Sign:
Ben Graham prefers companies' interest coverage to be at least 5. XRF Scientific Ltd has enough cash to cover all of its debt. Its financial situation is stable.
2. Debt to revenue ratio. The lower, the better.
XRF Scientific's Debt to Revenue Ratio for the quarter that ended in Dec. 2025 is
Z-Score model is an accurate forecaster of failure up to two years prior to distress. It can be considered the assessment of the distress of industrial corporations.
The zones of discrimination were as such:
When Z-Score is less than 1.81, it is in Distress Zones.
When Z-Score is greater than 2.99, it is in Safe Zones.
When Z-Score is between 1.81 and 2.99, it is in Grey Zones.
XRF Scientific has a Z-score of 14.27, indicating it is in Safe Zones. This implies the Z-Score is strong.
Good Sign:
Altman Z-score of 14.27 is strong.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
XRF Scientific (ASX:XRF) has a Financial Strength of 8 as of Dec. 2025. The financial strength rank measures the strength of a company's balance sheet based on revenue and debt. View historical data on XRF Scientific and its competitors. This is near median its historical median of 8.00. Over the past decade, XRF Scientific's Financial Strength has ranged from 6.00 to 9.00.
Is XRF Scientific's Financial Strength too high?
XRF Scientific's current Financial Strength of 8 is near median its 10-year median of 8.00. Over the past 10 years, this metric has ranged from a low of 6.00 to a high of 9.00. Overall, XRF Scientific has a GF Score™ of 95/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does XRF Scientific's Financial Strength compare to MMM and HON?
XRF Scientific's Financial Strength of 8 can be compared against companies in the Conglomerates industry. Historically, XRF Scientific's own Financial Strength has ranged from 6.00 to 9.00 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Financial Strength for a Conglomerates company?
A good Financial Strength depends on the Conglomerates industry context. However, Financial Strength should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Financial Strength mean?
A high Financial Strength can signal that a stock is expensive relative to its fundamentals. The financial strength rank measures the strength of a company's balance sheet based on revenue and debt. View historical data on XRF Scientific and its competitors. XRF Scientific's current Financial Strength is 8, which is near median its own 10-year median of 8.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is XRF Scientific stock overvalued right now?
Based on GuruFocus' analysis, XRF Scientific (ASX:XRF) is currently considered Fairly Valued. The stock's GF Value™ is A$1.67, compared to a current price of A$1.83 — trading 9.6% above its estimated fair value. The current Financial Strength is 8, which is near median its 10-year median of 8.00. XRF Scientific's overall GF Score™ is 95/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Financial Strength calculated?
Financial Strength is calculated from a company's financial statements. For XRF Scientific (ASX:XRF), the current Financial Strength is 8 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is XRF Scientific (ASX:XRF) Overvalued in 2026?
Based on GuruFocus' analysis, XRF Scientific stock appears to be overvalued.
The current stock price of A$1.83 is trading 9.6% above its estimated GF Value™ of A$1.67.
GuruFocus considers XRF Scientific to be Fairly Valued.
Key valuation signals for ASX:XRF:
Financial Strength: 8 (near median its 10-year median of 8.00)
GF Value™: A$1.67 vs. price of A$1.83 (9.6% above fair value)
No single metric tells the full story. See the ASX:XRF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
XRF Scientific Ltd is engaged in the business of manufacturing and marketing precious metal products, specialized chemicals and instruments for the scientific, analytical and mining industries. It operates through the following segments: Capital Equipment, Precious Metals, and Consumables. The company generates maximum revenue from the Capital Equipment segment that Manufactures sample preparation products and analytical instruments. Geographically, it derives a majority of revenue from Australia and also has a presence in Canada and Europe. Some of its product includes Electric Fusion Machines; Fusion Flux; Crushing and Pulverising, platinum lab ware and others.
95GF Score
Get the complete analysis for ASX:XRF
Financial Strength is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ASX:XRF has been successfully added to your 
